Lexaria Bioscience Corp. (LEXX)

0.7588 +0.03 (+3.82%) USD  |  NASDAQ  |  Jan 16, 16:00
0.7437 -0.02 (-1.99%) Pre-Market: 20:00
More

Lexaria Bioscience SG&A Expense (% of Quarterly Revenues)

SG&A Expense (% of Quarterly Revenues) Chart

View SG&A Expense (% of Quarterly Revenues) for LEXX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (% of Quarterly Revenues) Range, Past 5 Years

View SG&A Expense (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (% of Quarterly Revenues) Benchmarks

View SG&A Expense (% of Quarterly Revenues) Benchmarks
Start Trial
Oncolytics Biotech, Inc. --
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. --
Xenon Pharmaceuticals, Inc. Upgrade
ProMIS Neurosciences, Inc. --